Position in JNJ
as of Mar 31, 2026
· filed Apr 24, 2026
Position Value
$6,862,408
+$603,413 QoQ
Shares Held
28,074
-7.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026FRG Family Wealth Advisors LLC holds $26,306,263 across 8 Drug Manufacturers - General names. JNJ ranks #2 (26.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,209 | $7,550,391 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
28,074 | $6,862,408 | |
| 3 | ABBV |
AbbVie Inc.
|
23,411 | $5,091,658 | |
| 4 | MRK |
Merck & Co., Inc.
|
30,597 | $3,680,513 | |
| 5 | AMGN |
Amgen Inc
|
3,351 | $1,179,049 | |
| 6 | NVS |
Novartis AG
|
7,605 | $1,161,663 | |
| 7 | PFE |
Pfizer Inc
|
20,298 | $569,967 | |
| 8 | NVO |
Novo Nordisk A S
|
5,731 | $210,614 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,862,408 | 28,074 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $6,258,995 | 30,244 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $5,697,956 | 30,730 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,845,993 | 31,725 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,657,631 | 34,115 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,108,412 | 35,323 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,830,108 | 35,975 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $5,412,304 | 37,030 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $6,054,880 | 38,276 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $7,086,372 | 45,211 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $7,087,559 | 45,506 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $7,794,171 | 47,089 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $7,431,785 | 47,947 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $8,707,431 | 49,292 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $8,330,869 | 50,997 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $9,088,867 | 51,202 | Shares | Sole | 2022-07-11 | |
| 2022-03-31 | $9,075,416 | 51,207 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $8,744,585 | 51,117 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $8,341,959 | 51,653 | Shares | Sole | 2022-03-02 | |
| 2021-06-30 | $8,529,084 | 51,773 | Shares | Sole | 2022-03-02 | |
| 2021-03-31 | $8,508,892 | 51,773 | Shares | Sole | 2022-03-02 | |
| 2020-12-31 | $8,187,694 | 52,025 | Shares | Sole | 2022-03-02 | |
| 2020-09-30 | $7,702,306 | 51,735 | Shares | Sole | 2022-03-02 | |
| 2020-06-30 | $7,084,236 | 50,375 | Shares | Sole | 2022-03-02 | |
| 2020-03-31 | $6,390,620 | 48,735 | Shares | Sole | 2022-03-02 | |
| No filing history on record for this holder in this stock. | ||||||